2-Bromo-4-methylpyridine 99%

Greenovel Life Sciences Private Limited (GLSPL) is a privately held Indian company that was incorporated on September 26, 2020, marking its presence in the pharmaceutical industry for over three years. With its registered office located in Hyderabad, Telangana, India, GLSPL has been actively contributing to the sector by focusing on the development and supply of pharmaceutical products. The company's operations are in good standing, as evidenced by its active status and the timely filing of its Annual Returns and Financial Statements up to March 31, 2023, in compliance with the regulations set forth by the Ministry of Corporate Affairs (MCA).

GLSPL is a company limited by shares, which means that it is owned by its shareholders who hold shares in the company. The authorized capital of the company, as recorded by the MCA, is Rs 10.00 Lakh, indicating the maximum amount of share capital that the company can issue. Similarly, the paid-up capital, which represents the amount of capital that the company has received from its shareholders, is also Rs 10.00 Lakh. This demonstrates the company's financial stability and its ability to meet its obligations to its shareholders and the market.